0001375151-19-000036.txt : 20190319 0001375151-19-000036.hdr.sgml : 20190319 20190319190123 ACCESSION NUMBER: 0001375151-19-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190315 FILED AS OF DATE: 20190319 DATE AS OF CHANGE: 20190319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Michael P CENTRAL INDEX KEY: 0001355576 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19693159 MAIL ADDRESS: STREET 1: 887 GREAT NORTHERN WAY CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155303646820835.xml FORM 4 X0306 4 2019-03-15 0 0001375151 ZOGENIX, INC. ZGNX 0001355576 Smith Michael P C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 0 1 0 0 EVP, CFO, Treasurer & Sec. Common Stock 2019-03-15 4 M 0 1563 0 A 1801 D Common Stock 2019-03-15 4 F 0 541 51.88 D 1260 D Restricted Stock Units 2019-03-15 4 M 0 1563 0 D Common Stock 1563.0 4687 D Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018. Includes 238 shares purchased under the company's employee stock purchase plan which were not previously reported pursuant to the exemption under Rule 16b-3(c). Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock. Not applicable. /s/ Thomas Doyle, Attorney-in-fact for Michael Smith 2019-03-19